The Study of Efficacy and Safety of a 60-day Use of the Magnox Comfort Compared to the Placebo in Subjects With NLC

Inclusion Criteria

• •1. The study subject is informed and he/she was given enough time to think on his participation in the study and signed the informed consent form before the beginning of any procedures;
• •2. A study subject is a man or a woman over the age of 45 years;
• •3. The study subject has an established diagnosis of the nocturnal legs cramps;
• •4. The study subject understands the Ukrainian language;
• •5. The study subject has satisfactory results of the neurological examination of both lower extremities;
• •6. The study subject has a telephone and can use it permanently;
• •2. The study subject has less than 4 episodes of NLC during the 14-day screening period;
• •3. There is necessity for significant change in the treatment tactics.